Life Stem Genetics Stock Analysis
| LIFS Stock | USD 0.0002 0.00 0.00% |
Life Stem Genetics holds a debt-to-equity ratio of 0.024. Life Stem's financial risk is the risk to Life Stem stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Life Stem's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Life Stem's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Life Pink Sheet's retail investors understand whether an upcoming fall or rise in the market will negatively affect Life Stem's stakeholders.
For many companies, including Life Stem, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Life Stem Genetics, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Life Stem's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that Life Stem's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Life Stem is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Life Stem to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Life Stem is said to be less leveraged. If creditors hold a majority of Life Stem's assets, the Company is said to be highly leveraged.
Life Stem Genetics is overvalued with Real Value of 1.68E-4 and Hype Value of 2.0E-4. The main objective of Life Stem pink sheet analysis is to determine its intrinsic value, which is an estimate of what Life Stem Genetics is worth, separate from its market price. There are two main types of Life Stem's stock analysis: fundamental analysis and technical analysis.
The Life Stem pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Life |
Life Pink Sheet Analysis Notes
The company had not issued any dividends in recent years. Life Stem Genetics had 13:1 split on the 20th of September 2013. Life Stem Genetics Inc., a development stage company, focuses on establishing stem cell therapy based clinics worldwide. The company was founded in 2012 and is based in Beverly Hills, California. Life Stem operates under Biotechnology classification in the United States and is traded on OTC Exchange.The quote for Life Stem Genetics is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Life Stem Genetics contact Gloria Simov at 310-279-5234 or learn more at http://www.lifestemgenetics.com.Life Stem Genetics Investment Alerts
| Life Stem Genetics generated a negative expected return over the last 90 days | |
| Life Stem Genetics has some characteristics of a very speculative penny stock | |
| Life Stem Genetics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (38.76 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Life Stem Genetics currently holds about 35.73 K in cash with (38.7 K) of positive cash flow from operations. |
Life Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.79 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Life Stem's market, we take the total number of its shares issued and multiply it by Life Stem's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Life Stem Genetics, as well as the relationship between them.Life Stem Genetics Price Movement Analysis
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Weighted Moving Average calculates a weight for each value in Life Stem price series with the more recent values given greater weights.
Life Stem Outstanding Bonds
Life Stem issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Life Stem Genetics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Life bonds can be classified according to their maturity, which is the date when Life Stem Genetics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| US53219LAU35 Corp BondUS53219LAU35 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Life Stem Genetics Debt to Cash Allocation
Many companies such as Life Stem, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Life Stem Genetics currently holds 8.62 K in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. Debt can assist Life Stem until it has trouble settling it off, either with new capital or with free cash flow. So, Life Stem's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Life Stem Genetics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Life to invest in growth at high rates of return. When we think about Life Stem's use of debt, we should always consider it together with cash and equity.Life Stem Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Life Stem's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Life Stem, which in turn will lower the firm's financial flexibility.Life Stem Corporate Bonds Issued
About Life Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Life Stem prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Life shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Life Stem. By using and applying Life Pink Sheet analysis, traders can create a robust methodology for identifying Life entry and exit points for their positions.
Life Stem Genetics Inc., a development stage company, focuses on establishing stem cell therapy based clinics worldwide. The company was founded in 2012 and is based in Beverly Hills, California. Life Stem operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Life Stem to your portfolios without increasing risk or reducing expected return.Did you try this?
Run My Watchlist Analysis Now
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
| All Next | Launch Module |
Additional Tools for Life Pink Sheet Analysis
When running Life Stem's price analysis, check to measure Life Stem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Life Stem is operating at the current time. Most of Life Stem's value examination focuses on studying past and present price action to predict the probability of Life Stem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Life Stem's price. Additionally, you may evaluate how the addition of Life Stem to your portfolios can decrease your overall portfolio volatility.